Table 1.
Clinical characteristics of COVID-19 convalescent patients and healthy controls. CNS central nervous system, PNS peripheral nervous system, DOC disorder of consciousness, Q1 and Q3 first and third quartile, respectively. For each diagnostic group, the most common diagnosis is given (in brackets) as well as the COVID severity (1, mild; 2, moderate; 3, severe). Duration of infection: days between the first positive and the first negative SARS-CoV-2 test on nasopharyngeal swab (NPS) or bronchial aspirate
| COVID-19 patients | No COVID | |
|---|---|---|
| Age, median (Q1–Q3), years | 66 (58–76) | 65 (58–75) |
| Gender, male/female | 19/11 | 7/3 |
|
Brain injury with DOC history (hemorrhagic stroke) |
6 (4) | 6 (4) |
| COVID severity, median (range) | 2 (1–2) | – |
|
Injury of the CNS without DOC history (stroke and cerebrovascular disease) |
15 (8) | 3 (2) |
| COVID severity, median (range) | 2 (1–3) | – |
|
Disease of the PNS (peripheral neuropathy) |
9 (7) | 1 (1) |
| COVID severity, median (range) | 3 (1–3) | – |
| Duration of infection, median (Q1–Q3), days | 42 (32.5–58) | – |